Undiagnosed Breast Cancer

Failure to diagnose Breast Cancer

No early symptoms: This condition may have no early symptoms, and thus fail to be diagnosed in its early stages.

Undiagnosed prevalence of Breast Cancer:

estimated 1 million

Undiagnosed prevalence rate:

approx 1 in 272 or 0.37% or 1 million people in USA [about data]

Medical news about undiagnosed Breast Cancer:

The following medical news items are relevant to nondiagnosis of Breast Cancer:

• Breast cancer and litigation
• Breast cancer in young adults
• Fears of legal action result in 20 percent increase in breast clinic referrals
• Hispanic women generally receive late diagnosis and treatment of breast and cervical cancer
• Male breast cancer undiagnosed
• Negligent general physician sued over breast cancer
• Poor women are undereducated about cancer screening
• More news »

Undiagnosed Causes of Breast Cancer

As part of Breast Cancer diagnosis, consider whether any of these underlying medical Breast Cancer causes may have been overlooked:

• The cancer can return at the original site. This is called a local recurrence
• The cancer can recur nearby, such as in the chest. This is called a regional recurrence
• The cancer can spread to a distant location in the body, such as lymph nodes, bone marrow, or lungs. This is called a distant recurrence, or a metastasis
• More hidden causes »

Undiagnosed Diseases

Read our premium medical health articles on topics related to undiagnosed conditions in general, not necessarily specific to Breast Cancer:

• Failure to Diagnose
• Under-Diagnosed Diseases
• How Common is Failure to Diagnose?
• Conditions by Undiagnosed Prevalence
• More premium medical articles ... »

About undiagnosed conditions:

One possible misdiagnosis is the failure to correctly diagnose Breast Cancer leading to a person remaining with undiagnosed Breast Cancer. Any condition can potentially be missed and stay undiagnosed. For a general overview of diseases that are often undiagnosed, see Failure to Diagnose or Under-Diagnosed Diseases.